EDGAR Filing Documents for 0001178913-22-002461

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001178913-22-002461

Filing Date

2022-06-23

Accepted

2022-06-23 07:07:36

Documents

Period of Report

2022-06-23

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	zk2228043.htm	6-K	12633
2	EXHIBIT 1	exhibit_1.htm	EX-99	266441
3	EXHIBIT 2	exhibit_2.htm	EX-99	345342
4		image00001.jpg	GRAPHIC	4294
	Complete submission text file	0001178913-22-002461.txt		631396

Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739

Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131

RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 221033568
SIC: 2834 Pharmaceutical Preparations